Atlas Trials

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Clinical trial NCT01820962 · TERMINATED

Trial details

NCT number
NCT01820962
Sponsor
Maastricht University Medical Center
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hematological MalignanciesBacteremiaThrombosis
Start date
2006-07-01
Primary completion
2010-12-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.